Description
Bortezomib, marketed under the brand name BortiRel, It is an prescription medication that has been approved bortezomib (brand name Velcade) on May 13, 2003. Bortezomib is an injectable drug used to treat multiple myeloma and mantle cell lymphoma.
What is BortiRel (Bortezomib) ?
Bortezomib, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.
Common side effects include nausea, diarrhea, tiredness, low platelets, fever, numbness, low white blood cells, shortness of breath, rash and abdominal pain. Other severe side effects include low blood pressure, tumour lysis syndrome, heart failure, and reversible posterior leukoencephalopathy syndrome. It is in the class of medications known as proteasome inhibitor. It works by inhibiting proteasomes, cellular complexes that break down proteins.
Bortezomib was approved for medical use in the United States in 2003 and in the European Union in 2004. It is on the World Health Organization’s List of Essential Medicines.
Source Contents Click Here
How to order approved ” BortiRel (Bortezomib) for Injection” Medicine?
BortiRel (Bortezomib) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing BortiRel and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
